Posts Tagged ‘NPWT’

Always, Never, When? My approach to V.A.C. VERAFLO™ Therapy

Friday, September 22nd, 2017

Susan Mendez-Eastman RN, CWCN, CPSN

Should you consider using negative pressure wound therapy with instillation and dwell (NPWTi-d) on every wound ALWAYS? An experienced wound nurse discusses some contraindications.


ALWAYS, NEVER, When? My approach to V.A.C. VERAFLO™ Therapy - NPWTi-d


Susan Menendez-Eastman, RN, CWCN, CPSN

Susan Menendez-Eastman, RN, CWCN, CPSN

I am a huge proponent of V.A.C. VERAFLO™ Therapy, but I would NEVER endorse that you should ALWAYS use V.A.C. VERAFLO™ Therapy to treat a wound.  There are only a handful of situations where I would NEVER consider use of the therapy.  Wound care is dynamic and should be considered a continuum where patients and wounds are kinetic – the status, and therefore the needs, change. Goals of care also change, so to say any wound care treatment or therapy should ALWAYS or NEVER be used would be closed minded and fail to address the variability of wound care and healing.


Challenges of Wound Care: Bridging the Gap

Saturday, September 3rd, 2011

Challenges of Wound Care: Bridging the Gap will be presented by Josie F. Schantz MSN, RN-BC, WCC, Regional Professional Education Manager at this year’s Wild on Wounds National Conference in Las Vegas NV, September 7-10,2011.

Wound care is a relatively new field in medicine. Often times, there is a big gap that seems to exist between medical practice and using clinical data to change healthcare practices.  The goal of this educational offering is to teach healthcare professionals about the science of negative pressure wound therapy (NPWT).  We will summarize NPWT mechanisms of action, indications, contraindications and warnings. We will discuss benchmark tips and techniques when applying dressings. Lastly, we will discuss research studies that substantiate the clinical effectiveness of NPWT

For more information about the Wound Care Education Institute, please visit

Click Here To Register for the Wild on Wounds National Conference

NPWT in Home Care Under Spotlight by CMS

Saturday, June 11th, 2011

Nancy Morgan RN Message About NPWT and Home Care

This is for Clinicians that use Negative Pressure in the Home Care Environment ONLY.

CMS (Medicare) Competitive bidding process continues with Negative Pressure Wound Therapy (NPWT) under the spotlight. As seen with previous competitive bidding processes, companies and products with the lowest price will prevail. In order to bid competitively many NPWT companies will have to cut back on education, clinical support and other value added services so they can keep their pricing low enough to stay in the game. NPWT companies do not want to lose the bidding process, because losers will no longer receive Medicare reimbursement. (This will cut back your options for NPWT choices)

We must act now to make sure that our options for quality, not just cheapest, NPWT are available. Simply call, write, or email your local congressman at:

Tell your representative who you are, what you do and why they should ensure the CMS should institute accreditation & quality standards for NPWT suppliers, prior to bidding for a government contract.

These standards will ensure suppliers can deliver the essential elements for safe and effective use of NPWT in the home, such as requiring 24/7 clinical support along with educational support available to home care patients.”

Smith and Nephew will continue to compete in NPWT Market

Sunday, October 24th, 2010


District Court Invalidates KCI Patents and Renders Judgement in Favor of Smith & Nephew

(Sources: PRNewswire and

Full range of Smith & Nephew NPWT products continues to be available in U.S.
ST. PETERSBURG, Fla., Oct. 19 /PRNewswire-FirstCall/ — The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN; NYSE: SNN) today announced that the U.S. District Court for the Western District of Texas entered a favorable judgment in the patent litigation brought by Kinetic Concepts Inc. (NYSE: KCI) relating to the Smith & Nephew RENASYS™-F (Foam) dressing kit. The Court ruled that U.S. patents 5,645,081 and 7,216,651, licensed to KCI, are invalid due to obviousness. As a result of this ruling, the RENASYS™-F (Foam) dressing kit will continue to be fully available in the United States. This judgment overturns a previous jury verdict from March 10, 2010.

“We are pleased with the Court’s judgment that KCI’s patents are indeed invalid, which re-affirms our belief that our NPWT offering does not infringe any valid patents,” said Robin Carlstein, Senior Vice President, Smith & Nephew Advanced Wound Devices. “We look forward to continuing to compete in the dynamic NPWT market, providing clinicians and patients – the ultimate beneficiaries of this decision – with our wide and growing range of treatment options.”

This judgment is consistent with court decisions invalidating KCI’s related patents in the United Kingdom and Germany.

The RENASYS system enables clinicians to tailor NPWT to meet unique needs of patients and the specific requirements of their wounds, with clear improvements in patient comfort, ease of use and cost-effectiveness.

For more information about Smith & Nephew, please visit

FDA alerts healthcare providers about negative pressure wound therapy

Tuesday, November 17th, 2009

FDA alerts healthcare providers about negative pressure wound therapy

As Wound Care Certified professionals, many of you have used or are familiar with Negative Pressure Wound Therapy (NPWT). WCEI attempts to keep all students and WCC professionals up to date with current news and information. Today,the Food and Drug Administration has issued an alert about deaths and serious complications associated with the use of Negative Pressure Wound Therapy (NPWT). You can read more about this alert at McKnight’s Long Term Care News & Assisted Living

For more information about becoming Wound Care Certified, please visit Wound Care Education Institute’s website.